Track the HOYA株式会社 share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, HOYA株式会社 has recorded 6 insider filings. Market capitalisation: €8,354.5bn. The latest transaction was filed on 21 July 2026 (Holding update). Among the most active insiders: BlackRock Japan Co., Ltd.. All data is openly available.
Analysts rate HOYA株式会社 Strong Buy (bullish), based on 15 analysts. Average price target: JP¥30,380.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
HOYA Corporation is a Japanese company specializing in health and pharmaceutical products. It is listed on the XTKS market.